TY - JOUR
T1 - Obstructive sleep apnea risk and psychological health among non-Hispanic blacks in the Metabolic Syndrome Outcome (MetSO) cohort study
AU - Ceïde, Mirnova E.
AU - Williams, Natasha J.
AU - Seixas, Azizi
AU - Longman-Mills, Samantha K.
AU - Jean-Louis, Girardin
N1 - Funding Information:
This research was supported by funding from the National Institutes of Health: R25HL105444, R01HL095799, RO1MD004113, and U54NS081765. The funding source had no role in the design, conduct, or analysis of the study, or in the decision to submit the manuscript for publication.∗%blankline%∗
Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Introduction This study assessed associations of depression and anxiety with risk of obstructive sleep apnea (OSA) among non-Hispanic blacks in the Metabolic Syndrome Outcome (MetSO) study. Method A total of 1,035 patients participated. ARES™ score ≥6 defined high OSA risk. Moderate depression was defined by a CES-D score≥16. Moderate anxiety was measured by a BAI score≥16. Results The mean age was 62 ± 14 years; 70% were female. A total of 93% were diagnosed with hypertension; 61%, diabetes; and 72%, dyslipidemia; 90% were overweight/obese; 33% had a history of heart disease; and 10% had a stroke. Logistic regression analysis, adjusting for age and gender, showed that patients with depression had nearly two-fold increased odds of being at risk for OSA (OR 1.75, 95% CI 1.02-2.98, p<0.05). Patients with anxiety had three-fold increased odds of being at risk for OSA (OR 3.30, 95% CI 2.11-5.15, p<0.01). After adjusting for marital status and income, patients with anxiety had a 6% increase in OSA risk (OR 1.06, 95% CI 1.04-1.09, p<0.05), but depression was no longer significant. Conclusion Our results suggest that non-Hispanic blacks with metabolic syndrome who experience anxiety and/or depression should be screened for OSA.
AB - Introduction This study assessed associations of depression and anxiety with risk of obstructive sleep apnea (OSA) among non-Hispanic blacks in the Metabolic Syndrome Outcome (MetSO) study. Method A total of 1,035 patients participated. ARES™ score ≥6 defined high OSA risk. Moderate depression was defined by a CES-D score≥16. Moderate anxiety was measured by a BAI score≥16. Results The mean age was 62 ± 14 years; 70% were female. A total of 93% were diagnosed with hypertension; 61%, diabetes; and 72%, dyslipidemia; 90% were overweight/obese; 33% had a history of heart disease; and 10% had a stroke. Logistic regression analysis, adjusting for age and gender, showed that patients with depression had nearly two-fold increased odds of being at risk for OSA (OR 1.75, 95% CI 1.02-2.98, p<0.05). Patients with anxiety had three-fold increased odds of being at risk for OSA (OR 3.30, 95% CI 2.11-5.15, p<0.01). After adjusting for marital status and income, patients with anxiety had a 6% increase in OSA risk (OR 1.06, 95% CI 1.04-1.09, p<0.05), but depression was no longer significant. Conclusion Our results suggest that non-Hispanic blacks with metabolic syndrome who experience anxiety and/or depression should be screened for OSA.
KW - Metabolic syndrome
KW - Non-Hispanic blacks
KW - Obstructive sleep apnea
KW - Psychological health
UR - http://www.scopus.com/inward/record.url?scp=84947943146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947943146&partnerID=8YFLogxK
U2 - 10.3109/07853890.2015.1107186
DO - 10.3109/07853890.2015.1107186
M3 - Article
C2 - 26593384
AN - SCOPUS:84947943146
SN - 0785-3890
VL - 47
SP - 687
EP - 693
JO - Annals of Medicine
JF - Annals of Medicine
IS - 8
ER -
